Skip to content
OpenCapital
Get started

The Oncology Institute, Inc. TOI FLORIDA — Number of lease modifications

Similar metrics at other companies

Lantheus Holdings logo
LNTHLease Modification
$1.94M-66.5%
CareTrust logo
CTREFlorida — Number of facilities
2+100%
Amerant Bancorp logo
AMTBFlorida — Number of branches subleased
2—
IBEX Limited logo
IBEXNumber of lease renewals
1+300%
Lineage, Inc. logo
LINEFlorida — Number of buildings
1.50.0%
Tarsus Pharmaceuticals, Inc. logo
TARSOperating lease modification
$0-100%

Other financials

Income statement

See full
Revenue$147.4M+41.2%
Operating income-$6.5M+34.3%
Net income-$2.5M+87.3%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$30.3M-23.8%
Total debt$104.9M+2.5%
Total equity-$16.3M-421%
Total assets$168.2M+2.6%

Cash flow

See full
Operating cash flow-$2.2M+55.6%
CapEx$1.0M+218%
Free cash flow-$3.3M+38.7%

Valuation

See full
Market cap$511.91M+133%
Enterprise value$586.58M+108%
P/S0.9×+0.4×

Profitability

See full
Operating margin-6%-2.1pp
Net margin-8%-2.7pp
FCF margin-5.1%—

Returns & leverage

See full
Return on equity-277.6%-700pp
Debt / equity20.2×+17.3×
Current ratio1.5×-0.3×

Where this comes from

Reported directly by The Oncology Institute, Inc. in its filing.

Tagged under the XBRL concept toi:LesseeOperatingLeaseNumberOfLeasesExtended.

The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Oncology Institute, Inc.'s florida — number of lease modifications.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Oncology Institute, Inc.'s FLORIDA — number of lease modifications?
The Oncology Institute, Inc. (TOI) reported FLORIDA — number of lease modifications of 4 in Q1 2026.
What does FLORIDA — number of lease modifications mean?
This metric tracks the total count of operating lease agreements within the Florida geographic segment that have undergone formal extensions or modifications. It serves as a key indicator of real estate footprint stability and long-term commitment to specific clinical facility locations. Monitoring these modifications helps investors assess the company's operational continuity and potential future capital expenditure requirements for its oncology service centers.